Qnexa phentermine/topiramate: Preliminary data

Additionally, the oral cleft prevalence rate in 1,945 mother-infant dyads that were exposed to topiramate either alone or in combination with other anti-epileptic drugs in the first trimester was 0.36%. In a second control group of 13,614 mother-infant dyads who were not exposed to prior anti-epileptic drugs

Read the full 478 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE